KIT and acute myeloid leukemia: As expected, CPZ inhibited the growth of AML cells harboring either FLT3 ITD (#1, #5, and #7) or KIT D816V (#10), while it showed no effect (#11 and #16) or limited effects (#12, #17, and #19) on AML cells with FLT3 WT/KIT WT (Fig. 2d).